A prodrug is a medication or compound that metabolizes into a pharmacologically active drug after administration, offering opportunities to optimize the pharmaceutical property to improve bioavailability. Approximately 10% of all marketed drugs worldwide can be considered prodrugs. However, there are challenges for developing prodrugs.
The therapeutic rationale of a prodrug is to improve the physicochemical, biopharmaceutical, or pharmacokinetic properties of an active pharmaceutical ingredient (API). Key properties that prodrugs seek to modify generally fall within one or more of the ADME categories (Absorption, Distribution, Metabolism, and Excretion) with the end goal being the creation of a new chemical entity (NCE) that optimizes the performance, utility, and potential life-cycle management of the parent drug.
This week’s shared presentation is titled “A Prodrug Approach for Improving Bioavailability” from Dedong Wu at AstraZeneca. Dedong delivered this talk at our past Global Drug Bioavailability Summits earlier this year. This deck will give a brief introduction of the prodrug concept, intrinsic solubility improvement by prodrugs, as well as permeability enhancement by prodrugs. It additionally discusses in vivo molecule stability optimization by prodrugs and perspectives of prodrug design with examples. Scroll through the presentation below…
Are you looking to improve the performance of your drug products?
The next generation of drug and therapeutic delivery is here. Would you like to learn multiple new strategies and approaches to improve the performance of your drug products? Don’t miss your chance to attend 2021’s Peptide Drug Design & Delivery Virtual Summit (July 21-22, 2021) for only $499! Join 100’s of leading drug delivery, formulation and development experts this July and benefit from multiple expert sessions including:
- Precision medicine & healthcare delivery: making precision medicine a reality via novel technology advancements
- Advances in peptide-based drug discovery
- Designing optimal peptides; Peptidomimetics
- Rational and structure-based design of novel peptides
- Peptide conjugation techniques
- Targeted & localized delivery
- Cell penetrating peptides in molecular imaging and drug delivery
- Antimicrobial peptides in immunotherapy
- Peptide synthesis; Biosynthesis and modified peptides
- Discovery and development of protease inhibitors
- Breakthrough protein targets
- Peptide catalysts and enzyme mimicry
- And much, much more…
Attend and learn over 2 years worth of new product development strategies, formulation approaches, delivery technologies in just 2 days.